Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities
FDA Law Blog
SEPTEMBER 13, 2021
A May 2019 CMS final rule that would have required drug TV advertisements to disclose the WAC of the drug was challenged by a group of pharmaceutical companies and vacated on statutory grounds by the D.C. Finally, the HHS plan encourages Congress to create incentives to foster scientific innovation.
98 
Let's personalize your content